secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001628280-25-045106
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD reports prelim Q4 rev $5.9B (+8.3%); CFO DelOrefice to depart Dec 5; Roque interim CFO
--------------------------------------------------------------------------------

- Preliminary Q4 revenue ~$5.9B, up 8.3% reported, 3.9% organic; FY revenue ~$21.8B, up 8.2% reported, 2.9% organic.
- CFO Chris DelOrefice resigns effective Dec 5, 2025 to pursue new opportunity; departure not due to disagreement.
- Vitor Roque, SVP Finance, named interim CFO effective upon DelOrefice's departure; permanent search underway.
- FY2025 adjusted diluted EPS expected at or above midpoint of prior guidance.
- Headwinds in Pharma Systems vaccines and Biosciences academic/govt research; strong growth in Interventional, APM, Med Delivery Solutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828025045106/0001628280-25-045106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828025045106/bdx-20251009.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-045106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer